Instructions to Authors
- Title and scope of the article as agreed with the Editor-in-Chief or Managing Editor.
- All authors are requested to provide a statement of disclosure/conflicts of interest relevant to the article.
- The lead author should provide a correspondence address, and all authors should provide an email address.
- Articles may include up to five images/figures/tables (provided in a minimum resolution of 300dpi).
- For details on specific content types, please refer to the Types of Submissions section below Submissions.
- Articles should be submitted using the e-Press system at: www.epress.ac.uk/ver/webforms/author.php.
Articles accepted for publication include Editorials and Review articles.
Vascular and Endovascular Review endeavours to publish unbiased content. All articles submitted must be of an impartial nature. Following submission, articles will be subject to an independent double-blind peer review and in-house editing prior to publication. Edits will be made to ensure articles submitted adhere to house-style. All articles must receive final approval of the Editor-in-Chief and/or Section Editors before they can appear in the journal.
We will consider unsolicited submissions provided they meet our publication criteria. If you are interested in submitting a manuscript, please contact the Managing Editor at firstname.lastname@example.org
Types of Submissions
- Lengths generally range from 1,500 to 3,000 words (excluding references).
- Editorials should be accompanied by a brief summary (30–70 words).
- Lengths generally range from 1,500 to 4,000 words (excluding references).
- Review articles must be accompanied by an abstract (120–160 words) and a list of keywords (5–12 words).
- Please provide a clinical perspective, summarising the clinical implications of your review in two to five bullet points.
Content should be supplied in Microsoft Word, with all pages clearly numbered.
Title page – Should include the title of the article; author(s)’ full name, position and institution; an abstract and key words; any relevant conflicts of interest; corresponding address; and article word count (excluding references).
Article length – Each content type has its own word limit, included in the letter of invitation. Articles submitted with word counts exceeding the limit will either be returned for reduction by the author or be reduced in length by the Editor. Typically, articles generally range from 1,500 to 4,000 words (excluding references and figure titles).
Layout – Use headings within the text to make it easier to read and understand. Subdivide the text into main sections with subheadings. Keep these short and succinct and similar in sense and style.
Language – All articles should be written in UK English, free from jargon, and the writing should be clear and direct. All acronyms and abbreviations must be explained in full at first mention.
Figures – Tables, illustrations, screenshots and photographs – a maximum of five may be used. These are welcome where they add emphasis, clarity and/or interest to articles and should be clearly labelled with relevant captions. They must be referred to in the main text. All symbols and abbreviations used in figures must be defined. Authors are responsible for obtaining permission for all copyright material, including tables, figures and images.
Illustrations can be accepted as line drawings, mono or coloured or as photographs or slides (do not send glass-mounted slides/transparencies), but must be of a high quality. Do not send originals. Digital files can be used, but must be saved as .tif, .pdf or .jpeg files and be at least 300dpi.
Author Disclosures – Authors must disclose any conflicts of interest pertaining to the article. This includes any commercial interests that may be construed to have influenced opinion such as research funding, consultancy services, serving on speakers’ bureaus, travel expenses, appearance fees, the receipt of share options, or direct employment by a commercial entity. Conversely, please state clearly should there be no conflicts of interest to declare.
For more information and to download a Form for Disclosure of Potential Conflicts of Interest, which should be submitted with your manuscript, please visit: www.icmje.org/conflicts-of-interest/
Acknowledgements – The author(s) should acknowledge substantive contributions to the article, including receipt of financial assistance, materials and other resources.
Informed Consent – Authors should include a statement in the manuscript that informed consent was obtained, if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed. For more information please read: https://www.radcliffevascular.com/privacy-statement
Human and Animal Rights – If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for research involving humans https://www.wma.net/publications/# or the EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm
All articles must be fully referenced. References must be numbered in order of first mention. They must be indicated in the text by a number with the full list at the end of the article in numerical order.
Journal abbreviations are used as per Medline. Include the first three authors only. Details should be ordered as:
Surname Initials. Article title. Journal name year;volume:page numbers. doi: [doi number}. PMID: [PMID number}.
Example: Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008;1:209–18. doi:10.1161/CIRCEP.107.748103. PMID:19122847.
Mansbach H. Sumatriptan: looking back and looking forward. In: Humphrey P, Ferari M, Olesen J (eds). The Triptans: Novel Drugs for Migraine. New York: Oxford University Press, 2001;183–9.
Open Access, Copyright and Permission
Articles published within this journal are open access, which allows users to copy, redistribute and make derivative works for non-commerical purposes, provided the original work is cited correctly. The author retains all non-commerical rights for articles published under the CC-BY-NC 4.0 license.
Radcliffe Cardiology retains all commerical rights for articles herein unless otherwise stated. Permission to reproduce an article or any of its contents for commerical purposes, either in full or in part, should be sought from the publication's Managing Editor.
Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Evidence will need to be provided where permission has been granted upon request.
To support open access publication costs, Radcliffe Cardiology charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper as follows: £1,050 UK | €1,200 Eurozone | $1,369 all other countries.
(Submissions from the UK will be subject to the current UK VAT charge. A VAT registration number should be supplied to ensure any invoice accounts for VAT at your local relevant rate. Those not registered for VAT will have VAT added.)
APC Waivers and Discounts
A 100% waiver is available for all papers which are solicited directly from Radcliffe Cardiology.
Authors from low-income countries as defined by the World Bank are eligible for a full waiver of the APC charge. Authors from middle-income countries are eligible for a 50% waiver. Discretionary waivers may also be considered.
Radcliffe Cardiology remains dedicated to helping researchers to disseminate scientific information globally and is actively working to partner with individual institutions to offer full or partial APC discounts. Institutional agreements will be listed here. If you are an institution looking to partner with us, or think your institution should, then please contact the Publishing Director.
To ensure editorial integrity, the waiver process is not handled by the journal Managing Editors. Authors should submit a waiver request during the electronic submission process.
Peer Review Process
All articles are subject to independent double-blind peer review following submission. The peer reviewers are selected on the basis of their expertise in the article subject matter. Following review, manuscripts are either accepted without modification, accepted pending modification, in which case the manuscripts are returned to the author(s) to incorporate required changes, or rejected outright.
The Editor-in-Chief reserves the right to accept or reject any proposed amendments.
Once the authors have revised a manuscript in accordance with the reviewers’ comments, the manuscript is returned to the reviewers to ensure the revised version meets their quality expectations. Once approved, the manuscript is sent to the Editor-in-Chief for final approval prior to publication.
Proofs will be sent to the corresponding author following the first stage of editing. Any requests for changes must be returned by the deadline given. Only minor changes can be made at the proofing stage; major changes will not be accepted. Articles are considered final upon initial submission.
Whenever possible, the full manuscript will be published; however, due to pagination constraints this cannot be guaranteed. In such circumstances the author will be informed of any changes prior to publication.
All accepted manuscripts will be subject to editorial revisions for clarity, punctuation, syntax and conformity to house style. Wherever possible, the author(s) will be fully involved in the editorial process, although the final decision remains with the publisher.
Errors and Omissions
Radcliffe Vascular will take every care possible to try to ensure that all content is reproduced correctly; however, due to human or mechanical errors we cannot guarantee the accuracy, adequacy or completeness of any information and cannot be held responsible for any errors or omissions, or for the results obtained from the use thereof.
Reprints of all published articles are available to authors, institutions and commercial organisations. Please contact Rob Barclay at email@example.com
Rosie Scott firstname.lastname@example.org
Managing Editor, Vascular & Endovascular Review
Mr Stephen Black email@example.com
Editor-in-Chief, Vascular & Endovascular Review